Potential for cross-contamination from use of a needleless injector.
BACKGROUND
Medical devices that are used on patients in fields containing potentially infectious body fluids can become contaminated and transmit infectious agents to other sites on the patient or to other patients if the devices are not properly cleaned and decontaminated after use on each patient treatment site. One such device is the needleless or jet injector, which is widely used in medicine and dentistry to deliver local anesthetic in procedures such as bone marrow aspirations, lumbar punctures, and cutaneous and intraoral injections. This study was conducted to determine whether cross-contamination can occur on in vitro reuse of a needleless injector and whether a manufacturer's recommended method of injector decontamination (ie, immersion sterilization) is effective in the prevention of cross-contamination.


METHODS
The study was performed with new autoclaved injectors, fluorescein dye, and Streptococcus crista (the bacteria commonly found in saliva) in the field of use to determine whether these devices can become contaminated during use and carry over the contamination to other sites during immediate reuse.


RESULTS
Fluorescein dye and bacteria tests with the needleless injectors showed that contamination or carryover does occur. It appeared to reduced to a minimum when a autoclaved, sterile rubber cap used over the head of the device during injection was replaced between each use, although replacement of the rubber cap alone did not prevent carryover. Immersion of the head of the injector in a 2% glutaraldehyde solution for 30 minutes followed by a sterile water rinse and the replacement of the rubber cap with a sterile cap between uses was shown to curtail bacterial growth and prevent cross-contamination on immediate reuse of the device.


CONCLUSIONS
This study demonstrated that needleless injectors become contaminated during in vitro use and direct contact with contaminated surfaces and that needless injectors carry over the contamination to subsequent sites of release. The replacement of the injector's rubber cap with a new one after initial discharge or the removal of an exposed rubber cap and immersion of the head of the injector in 2% glutaraldehyde followed by a rinse of the head in sterile water, as recommended by one injector manufacturer, can minimize or eliminate the carryover.
Weintraub
A M
AM
Office of Clinic Management and Patient Services, University of Pennsylvania School of Dental Medicine, Philadelphia 19104-6003, USA.
Ponce de Leon
M P
MP
D003287:Contrast Media / Q000032:analysis; D003428:Cross Infection / Q000635:transmission*; D004866:Equipment Contamination; D004867:Equipment Design; D004864:Equipment and Supplies / Q000382:microbiology*; D019793:Fluorescein / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous / Q000295:instrumentation*; D012016:Reference Values; D012307:Risk Factors; D013291:Streptococcus / Q000302:isolation & purification*
D003287:Contrast Media; D019793:Fluorescein